AstraZeneca vaccine still relevant: Expert

Let’s discuss government’s decision to put a temporary hold on the rollout of the Astrazeneca COVID-19 vaccine. A study has shown it's only 22 percent effective against the local Covid-19 variant in mild to moderate cases. However researchers are still confident it will provide protection against severe cases. #eNCA​ Courtesy #DStv403

JOHANNESBURG - Clinical trials on AstraZeneca's COVID-19 vaccine have only shown a 22-percent efficiency against the variant first discovered in South Africa.

But doctors and researchers are confident it will prevent severe illness and death from COVID-19. 

Government is halting the rollout of the vaccine temporarily following the results of the trial.

READ: WATCH: Experts find positives in AstraZeneca debacle

Research and innovation professor Mosa Moshabela at UKZN says the AstraZeneca vaccine should not be written off just yet.

Meanwhile, 183 more COVID-19 related deaths were reported in the last 24 hours, with 1,376 new cases. 


Paid Content